Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-02-01

FDA Approved: GLYCEROL PHENYLBUTYRATE — Original Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved glycerol phenylbutyrate under Original Application (NDA 203284) from Lupin Pharmaceuticals for the treatment of urea cycle disorders.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Glycerol phenylbutyrate (glycerol phenylbutyrate)

Snippet

ORIG AP for GLYCEROL PHENYLBUTYRATE (GLYCEROL PHENYLBUTYRATE)